Top Markets
Coin of the day
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
株式のランク #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
株価
$0.617
最終同期: 2024-10-14
時価総額
$6.13M
変化(1日)
0.49%
変化(1年)
0.00%
US
取引 Kineta, Inc. (KA)

カテゴリー

Kineta, Inc.(KA)のEPS
March 2025 時点のEPS TTM: $-0.66
Kineta, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-0.66です。2023年末には、EPSは$-1.28で、2022年のEPS$-12.80と減少でした。
Kineta, Inc.のEPS履歴(2015から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-0.66 -53.52%
2024 $-1.42 10.94%
2023 $-1.28 -90.00%
2022 $-12.80 57.25%
2021 $-8.14 -80.27%
2020 $-41.26 -74.51%
2019 $-161.86 -28.02%
2018 $-224.87 -31.33%
2017 $-327.48 17.86%
2016 $-277.86 97.27%
2015 $-140.85 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -2,724.24%
US
$27.74 -4,303.03%
NL
- -
CH
- -
KR
$13.70 -2,175.77%
BE